fiveonefour | $17,000,000 | (Sep 5, 2025)
Sesh Products | $40,000,000 | (Sep 5, 2025)
Pointsville | Undisclosed Amount | (Sep 5, 2025)
Certified by Founder
Lodge
OncoPep, Inc.
start up
United States
- Boston, Massachusetts
- 09/12/2021
- Series D
- $11,000,000
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
- Industry Biotechnology Research
- Website https://oncopep.com/
- LinkedIn https://www.linkedin.com/company/oncopep-inc./
Augment | $85,000,000 | (Sep 5, 2025)
Plural(US) | $7,000,000 | (Sep 5, 2025)
Hello Patient | $22,500,000 | (Sep 5, 2025)
Euclid Power | $20,000,000 | (Sep 5, 2025)
Lead | $70,000,000 | (Sep 5, 2025)
Pave Finance | $14,000,000 | (Sep 5, 2025)
throxy (yc x25) | $6,200,000 | (Sep 5, 2025)
Human Behavior (YC X25) | $5,000,000 | (Sep 5, 2025)
FlexifyMe | $2,400,000 | (Sep 5, 2025)